Fig 7 - by Vianney Guibourd de Luzinais (16871842)

“…<p>Evolution of <i>R</i> ratio (total consumer biomass change divided by NPP change) as a function of SST increase relative to the reference period: where NPP is expected to decrease (a) or increase (b) under GFDL-SSP5-8.5. …”

High glucose-containing media attenuates the degradation of internalized oAβ in mixed glia cultures. by Yung-Cheng Huang (3443450)

Subjects:

Lysosomal hydrolase activities of astrocytes and microglia in mixed glia are quantified in a cell type-specific manner. by Yung-Cheng Huang (3443450)

Subjects:

FASN upregulation induced by HSV-1 is strain-independent. by Camilla Albano (16446679)

Subjects:

FASN modulation impacts HSV-1 replication and infectivity. by Camilla Albano (16446679)

Subjects:

Annexin A2 accumulates in the nucleus and decreases in the cytoplasm in response to genotoxic agents. by Patricia A. Madureira (114480)

Mutation of <i>talB</i> in BAI3 results in a decrease of virulence partially complemented by the induction of <i>OsERF#123</i>. by Tuan T. Tran (5335004)

Glycosylation profiling of SARS-CoV-2 antigens produced in mammalian (HEK) and insect (Sf21) cells. by Marie Le Berre (6299012)

Supplementary Videos (File S3) show a step-by-step protocol for preparing and connecting <i>Apis mellifera</i> workers to the electrical measurement system. by Juan P. Hernández (22216133)

Inner medullary expression of the V2 vasopressin receptor. by Sophie Constantin Lütken (689916)

Subjects:

Spatial patterns of projected total consumer biomass relative changes in percent. by Vianney Guibourd de Luzinais (16871842)

S4 Fig - by Vianney Guibourd de Luzinais (16871842)

Evolution of R ratio (total consumer biomass change divided by NPP change) in regards to SST increase relative to reference period. by Vianney Guibourd de Luzinais (16871842)

“…<p>Where NPP is expected to decrease (a), or increase (b) under IPSL-SSP5-8.5 combination. …”

Polymorphisms in <i>CYP1B1</i>, <i>CYP3A5</i>, <i>GSTT1</i>, and <i>SULT1A1</i> Are Associated with Early Age Acute Leukemia by Bruno Almeida Lopes (740876)

“…Using data from the Brazilian Collaborative Study Group of Infant Acute Leukemia (2000–2012), 350 cases and 404 age-matched controls and 134 mothers of cases and controls were genotyped to explore polymorphisms in genes of the estrogen metabolism pathway: <i>CYP1B1</i> (c.1294C>G, rs1056836), <i>CYP3A4</i> (c.-392A>G, rs2740574), <i>CYP3A5</i> (c.219-237G>A, rs776746), <i>GSTM1/GSTT1</i> deletions, and <i>SULT1A1</i> (c.638G>A, rs9282861; and c.667A>G, rs1801030). …”

SAMHD1 siRNA decreases both anti-SAMHD1 and anti-pT592-SAMHD1 staining. by Simone De Meo (9427803)

Assays of TUNEL revealed a decreased number of apoptotic cell after oroxylin A treatment. by Shu-Fang Lin (4167091)

Decreased activity of FASII favors the cold growth of the <i>ΔcshA</i> strain. by Vanessa Khemici (814639)

“…<i>fapR</i> mRNA levels were quantified by RT-qPCR using 16S rRNA as reference gene on total RNAs extracted from <i>wt</i> strain (PR01), <i>ΔcshA</i> strain (PR01-ΔcshA), and suppressor strains <i>ΔcshA/accC</i>^<i>M385V</i> (C51), <i>ΔcshA/accC</i>^<i>T183I</i> (sup30), <i>ΔcshA/accD</i>^<i>F253V</i> (sup17), <i>ΔcshA/accD</i>^<i>A164V</i> (sup16), <i>ΔcshA/birA</i>^{<i>D320F-FsX28</i>} (C58), <i>ΔcshA/birA</i>^{<i>R280stop</i>} (sup1) and <i>ΔcshA/bioY</i>^{<i>P123R-FsX1</i>} (C66), all at exponential growth phase in MH medium at 25°C. n = 5 for <i>ΔcshA</i>, <i>4 for wt</i> and 3 for all others. …”

Table_2_Beneficial Effect of a Selective Adenosine A2A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease.XLSX by Emilie Faivre (5507582)

“…Interestingly, MSX-3 treatment led to a significant decrease of Aβ1-42 levels in the cortex of APP/PS1dE9 animals, while Aβ1-40 increased, thereby strongly affecting the Aβ1-42/Aβ1-40 ratio. …”

Table_3_Beneficial Effect of a Selective Adenosine A2A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease.XLSX by Emilie Faivre (5507582)

“…Interestingly, MSX-3 treatment led to a significant decrease of Aβ1-42 levels in the cortex of APP/PS1dE9 animals, while Aβ1-40 increased, thereby strongly affecting the Aβ1-42/Aβ1-40 ratio. …”

Table_4_Beneficial Effect of a Selective Adenosine A2A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer’s Disease.XLSX by Emilie Faivre (5507582)

“…Interestingly, MSX-3 treatment led to a significant decrease of Aβ1-42 levels in the cortex of APP/PS1dE9 animals, while Aβ1-40 increased, thereby strongly affecting the Aβ1-42/Aβ1-40 ratio. …”